|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
0 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$ - $ |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile AccuStem Sciences is an early- stage life sciences company focused on developing and commercializing products for the treatment and management of many cancers. The principal activities of Co. are that of a genomics-based personalized medicine business, particularly focused on breast cancer patients. Co.'s primary product candidate is StemPrintER, a 20-gene prognostic assay intended for the prediction of the risk of distant recurrence in luminal, Endocrine receptor positive/HER2-negative breast cancer patients. StemPrintER has a biological basis in the stem cell biology and interrogates the intrinsic content and aggressiveness of cancer stem cells of the primary tumor.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) ![](../../images/information.jpg) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
43,229 |
Total Buy Value |
$0 |
$0 |
$0 |
$45,920 |
Total People Bought |
0 |
0 |
0 |
1 |
Total Buy Transactions |
0 |
0 |
0 |
4 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-04-04 |
2024-01-02 |
2023-07-04 |
2022-07-04 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Cerrone Gabriel M |
Director |
|
2022-12-30 |
4 |
B |
$1.40 |
$7,000 |
I/I |
5,000 |
3,864,452 |
2.17 |
- |
|
Cerrone Gabriel M |
Director |
|
2022-12-02 |
4 |
B |
$1.42 |
$5,295 |
I/I |
3,729 |
3,859,452 |
2.17 |
- |
|
Cerrone Gabriel M |
Director |
|
2022-11-18 |
4 |
B |
$1.05 |
$25,725 |
I/I |
24,500 |
3,855,723 |
2.25 |
- |
|
Cerrone Gabriel M |
Director |
|
2022-08-01 |
4 |
B |
$0.79 |
$7,900 |
I/I |
10,000 |
3,831,223 |
2.17 |
- |
|
Cerrone Gabriel M |
Director |
|
2022-04-26 |
4 |
B |
$1.49 |
$7,846 |
I/I |
5,266 |
3,801,226 |
2.17 |
- |
|
Cerrone Gabriel M |
Director |
|
2022-04-25 |
4 |
B |
$1.35 |
$5,644 |
I/I |
4,181 |
3,795,960 |
2.17 |
- |
|
Blosser Wendy E |
Chief Executive OfficerOfficer |
|
2022-03-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,000 |
|
- |
|
Cerrone Gabriel M |
Director |
|
2021-12-02 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,791,779 |
|
- |
|
Simon Willy Jules |
Director |
|
2021-12-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
413 |
|
- |
|
9 Records found
|
1
|
Page 1 of 1 |
|
|